The latter two (axitinib and pazopanib) are in clinical trials, the results of which were presented (June 7) at the American Society of Clinical Oncology meeting.
American | American Civil War | American Broadcasting Company | American football | African American | American Idol | American Revolutionary War | American Revolution | Society of Jesus | Royal Society | American Association for the Advancement of Science | American Red Cross | National Geographic Society | American Library Association | American Museum of Natural History | American Express | American Academy of Arts and Sciences | American League | American Association | American Heart Association | American comic book | American Institute of Architects | American Airlines | American Hockey League | Spanish-American War | Pan American Games | American Cancer Society | Whitney Museum of American Art | American Ballet Theatre | American Legion |
In May 1992, researchers from the University of the Witwatersrand (Wits) in South Africa presented early results of a randomised control trial (RCT) at the annual meeting of the American Society of Clinical Oncology (ASCO) in San Diego.
Vogelzang is the 2012 Chair for the American Society of Clinical Oncology's (ASCO) Cancer Communications Committee, the current Vice Chair of the GU Committee and a member of the GU Translational Medicine Intergroup Committee for Southwest Oncology Group.
•
Vogelzang served on committees for the American Society of Clinical Oncology (ASCO), as well as its board of directors from 1993 to 1996, and is a former president of the Illinois Division of the American Cancer Society.